BioGend Therapeutics Co., Ltd. (6733.TWO)
TWD 33.0
(-0.6%)
TWD 33.0
(-0.6%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 109.9 Million | 31.44 Million | 9.26 Million | 1.39 Million | 1.46 Million |
| Cost of Revenue | 20.29 Million | 8.66 Million | 6.21 Million | 662 Thousand | 1.27 Million |
| Gross Profit | 89.61 Million | 22.77 Million | 3.05 Million | 731 Thousand | 185 Thousand |
| Operating Expenses | 266.15 Million | 241.99 Million | 167.36 Million | 134.34 Million | 167.29 Million |
| Selling, General and Administrative Expenses | 95.16 Million | 75.72 Million | 54.09 Million | 40.13 Million | 34.55 Million |
| Research and Development Expenses | 170.99 Million | 166.26 Million | 113.27 Million | 94.2 Million | 132.74 Million |
| Other Expenses | - | 816 Thousand | 28.52 Million | -86 Thousand | - |
| Cost and Expenses | 286.44 Million | 250.65 Million | 173.57 Million | 135 Million | 168.57 Million |
| Operating Income | -176.54 Million | -213.8 Million | -144.24 Million | -145.58 Million | -167.11 Million |
| Interest Expense | 262 Thousand | 91 Thousand | 18 Thousand | 5000.00 | - |
| Income Tax Expense | -8.3 Million | -8.39 Million | -5.78 Million | - | - |
| Earnings before Tax | -169.22 Million | -213.89 Million | -144.26 Million | -145.59 Million | -162.9 Million |
| Net Income | -156.32 Million | -184.45 Million | -138.48 Million | -145.59 Million | -162.9 Million |
| Earnings Per Share Basic | -1.30 | -1.79 | -1.37 | -1.64 | -2.01 |
| Earnings Per Share Diluted | -1.30 | -1.79 | -1.37 | -1.64 | -2.01 |
| Weighted Average Shares Outstanding | 120.28 Million | 103.07 Million | 101.28 Million | 88.53 Million | 81.04 Million |
| Weighted Average Shares Outstanding (Diluted) | 120.28 Million | 103.07 Million | 101.28 Million | 88.53 Million | 81.24 Million |
| Gross Margin | 0.82 | 0.72 | 0.33 | 0.52 | 0.13 |
| EBIT Margin | -1.03 | -5.11 | -12.52 | -90.74 | -101.99 |
| Profit Margin | -1.42 | -5.87 | -14.94 | -104.52 | -111.50 |
| EBITDA | -113.1 Million | -160.62 Million | -104.71 Million | -112.15 Million | -144.79 Million |
| Earnings Before Tax Margin | -1.61 | -6.80 | -15.56 | -104.51 | -114.38 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 37.26 Million | 35.55 Million | 39.57 Million | 109.9 Million | 21.05 Million | 38.46 Million |
| Cost of Revenue | 7.56 Million | 6.25 Million | 5.76 Million | 20.29 Million | 5.84 Million | 5.76 Million |
| Gross Profit | 29.7 Million | 29.29 Million | 33.8 Million | 89.61 Million | 15.21 Million | 32.7 Million |
| Operating Expenses | 72.28 Million | 47.86 Million | 74.11 Million | 266.15 Million | 67.05 Million | 58.79 Million |
| Selling, General and Administrative Expenses | 32.3 Million | 24.47 Million | 28.07 Million | - | 22.43 Million | 24.25 Million |
| Research and Development Expenses | 39.97 Million | 23.38 Million | 46.03 Million | - | 44.61 Million | 34.53 Million |
| Other Expenses | 76 Thousand | 358 Thousand | -528 Thousand | 1.49 Million | 1.65 Million | 138 Thousand |
| Cost and Expenses | 79.84 Million | 54.12 Million | 79.87 Million | 286.44 Million | 72.89 Million | 64.55 Million |
| Operating Income | -40.74 Million | -17.37 Million | -39.69 Million | -168.96 Million | -47.81 Million | -24.18 Million |
| Interest Expense | 56 Thousand | 60 Thousand | 65 Thousand | 262 Thousand | 62 Thousand | 65 Thousand |
| Income Tax Expense | -2.09 Million | -2.09 Million | -2 Million | -8.3 Million | -2.09 Million | -2.09 Million |
| Earnings before Tax | -40.8 Million | -17.43 Million | -39.76 Million | -169.22 Million | -47.87 Million | -24.24 Million |
| Net Income | -34.88 Million | -10.96 Million | -32.7 Million | -156.32 Million | -42.36 Million | -30.02 Million |
| Earnings Per Share Basic | -0.28 | -0.09 | -0.27 | - | -0.36 | -0.26 |
| Earnings Per Share Diluted | -0.28 | -0.09 | -0.27 | - | -0.36 | -0.26 |
| Weighted Average Shares Outstanding | 124.58 Million | 123.07 Million | 121.67 Million | 120.28 Million | 117.68 Million | 115.47 Million |
| Weighted Average Shares Outstanding (Diluted) | 124.58 Million | 123.07 Million | 121.67 Million | 120.28 Million | 117.68 Million | 115.47 Million |
| Gross Margin | 0.80 | 0.82 | 0.85 | 0.82 | 0.72 | 0.85 |
| EBIT Margin | -0.74 | -0.12 | -0.65 | - | -1.61 | -0.27 |
| Profit Margin | -0.94 | -0.31 | -0.83 | -1.42 | -2.01 | -0.78 |
| EBITDA | -27.43 Million | -4.34 Million | -25.86 Million | - | -33.97 Million | -10.42 Million |
| Earnings Before Tax Margin | -1.09 | -0.49 | -1.00 | -1.54 | -2.27 | -0.63 |
GKOS
SONN
600523
HLG
RKDL
0LFS